Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a precise prostate surgery predict better outcomes? a new study aims to find out.

NCT ID NCT07699718

Knowledge-focused Sponsor: Necmettin Erbakan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study follows men aged 45 and older who are scheduled for surgery that removes only the middle part of an enlarged prostate (the median lobe). The goal is to see which factors before surgery—like symptoms, urine flow, and prostate shape—are linked to success one year later. Researchers hope to create a tool that helps doctors decide who will benefit most from this targeted approach.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better select which men will benefit from a less invasive surgery for an enlarged prostate, reducing the need for repeat treatments.
What could go wrong
This is an observational study, not a test of a new treatment. It will not prove that one surgical method is better than another, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 420 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Men aged 45 years or older with moderate-to-severe lower urinary tract symptoms or urinary retention attributed to benign prostatic obstruction, in whom preoperative evaluation suggests median lobe-dominant or median lobe-related obstruction and who are scheduled to undergo selective median lobe transurethral surgery as part of routine clinical care at participating centers.

Ages

45 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male patients aged 45 years or older. * Moderate-to-severe lower urinary tract symptoms due to benign prostatic obstruction or urinary retention requiring transurethral surgery. * Preoperative findings suggesting median lobe-dominant or median lobe-related obstruction. * Planned selective median lobe-only TURP, HoLEP, or anatomical endoscopic enucleation as part of routine clinical care. * Available baseline International Prostate Symptom Score, uroflowmetry and/or postvoid residual volume, prostate volume, intravesical prostatic protrusion measurement, and cystoscopic assessment. * Ability to provide written informed consent and comply with the follow-up schedule. Exclusion Criteria: * Previous prostate surgery for benign prostatic hyperplasia. * Known urethral stricture requiring treatment before or during the index procedure. * Known neurogenic lower urinary tract dysfunction. * Active prostate cancer or bladder cancer requiring treatment that may confound urinary outcomes. * Planned complete TURP, complete HoLEP/AEEP, or lateral lobe-dominant surgery. * Severe kissing lateral lobe obstruction considered to require complete surgery rather than selective median lobe surgery. * Inability to provide valid baseline or follow-up outcome data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign prostatic hyperplasia Benign prostatic obstruction Lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH) Median lobe prostatic enlargement Urinary retention

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Necmettin Erbakan University, Meram Faculty of Medicine

    Konya, Konya, 42090, Turkey (Türkiye)

  • University of Health Sciences Türkiye, Van Training and Research Hospital

    Van, Edremit, 65140, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.